The Nasdaq Stock Market® Kicks Off the New Year With Strong ETP Momentum
February 08 2016 - 8:00AM
Nasdaq (Nasdaq:NDAQ), the single largest U.S. equity exchange by
market share, announced during the month of January, a collection
of new and transitioned listings to further solidify its place as a
quality primary listing and trading venue for ETPs.
“Our expanding portfolio of ETP listings is highly reflective of
our positive outlook for the product category in 2016 and beyond,”
said Jeff McCarthy, Vice President and Head of ETP Listings at
Nasdaq. “We are excited to build new and grow existing
relationships with issuers who - in a growing trend - want
diversification and are looking for leadership as part of their
core risk-management strategies. Nasdaq is focused on engaging with
market participants to advocate and create infrastructure to
support an exchange traded product market.”
Nasdaq ETF Listing Highlights in January:Nasdaq
saw 12 transitions to its platform from competitive listing
venues:
- BlackRock Inc. announced plans to switch the following 10 of
its iShares ETFs to Nasdaq; the switches officially took place
February 2, 2016:
- iShares 20+ Year Treasury Bond ETF (NASDAQ: TLT)
- iShares Asia 50 ETF (NASDAQ: AIA)
- iShares MSCI New Zealand Capped ETF (NASDAQ: ENZL)
- iShares MSCI Brazil Small-Cap ETF (NASDAQ: EWZS)
- iShares Global Infrastructure ETF (NASDAQ: IGF)
- iShares Core MSCI Total International Stock ETF (NASDAQ:
IXUS)
- iShares Morningstar Mid-Cap Value ETF (NASDAQ: JKI)
- iShares MSCI China ETF (NASDAQ: MCHI)
- iShares MSCI EAFE Small-Cap ETF (NASDAQ: SCZ)
- iShares 0-5 Year Investment Grade Corporate Bond ETF (NASDAQ:
SLQD)
- Van Eck announced it will change the primary listing venue for
the following two funds to Nasdaq; the switches officially took
place February 1, 2016:
- Market Vectors Biotech ETF (NASDAQ: BBH)
- Market Vectors Pharmaceutical ETF (NASDAQ: PPH)
Additionally, Nasdaq was the premier exchange of choice for five
new ETF launches:
- Van Eck expanded its relationship with Nasdaq by listing a new
product:
- Market Vectors Generic Drugs ETF (NASDAQ: GNRX)
- Legg Mason entered the ETF arena with its very first
products:
- Legg Mason Developed ex-US Diversified Core ETF (NASDAQ:
DDBI)
- Legg Mason Emerging Markets Diversified Core ETF (NASDAQ:
EDBI)
- Legg Mason US Diversified Core ETF (NASDAQ: UDBI)
- Legg Mason Low Volatility High Dividend ETF (NASDAQ: LVHD)
In 2015, The Nasdaq Stock Market®, the single largest U.S.
equity exchange by market share increased new ETF listings by
approximately 43 percent and reached a total number of 219 listed
ETFs, after adding 54 new listings that year. Of these funds, 19
represented transitioned funds from competitive exchanges and 18
represented index switches as well. For issuers who want to learn
more about opportunities to list and grow on The Nasdaq Stock
Market®, please visit our website or email
etflistings@nasdaq.com.
About Nasdaq: Nasdaq (Nasdaq:NDAQ) is a leading
provider of trading, clearing, exchange technology, listing,
information and public company services across six continents.
Through its diverse portfolio of solutions, Nasdaq enables
customers to plan, optimize and execute their business vision with
confidence, using proven technologies that provide transparency and
insight for navigating today's global capital markets. As the
creator of the world's first electronic stock market, its
technology powers more than 70 marketplaces in 50 countries, and 1
in 10 of the world's securities transactions. Nasdaq is home to
more than 3,700 listed companies with a market value of
approximately $9.6 trillion and nearly 10,000 corporate clients. To
learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
Cautionary Note Regarding Forward-Looking Statements The matters
described herein contain forward-looking statements that are made
under the Safe Harbor provisions of the Private Securities
Litigation Reform Act of 1995. These statements include, but are
not limited to, statements about Nasdaq and its products and
offerings. We caution that these statements are not guarantees of
future performance. Actual results may differ materially from those
expressed or implied in the forward-looking statements.
Forward-looking statements involve a number of risks, uncertainties
or other factors beyond Nasdaq's control. These factors include,
but are not limited to factors detailed in Nasdaq's annual report
on Form 10-K, and periodic reports filed with the U.S. Securities
and Exchange Commission. We undertake no obligation to release any
revisions to any forward-looking statements.
Nothing contained herein should be construed as investment
advice from Nasdaq, either on behalf of a particular financial
product or an overall investment strategy. Nasdaq makes no
recommendation to buy or sell any financial product or any
representation about the financial condition of any company or
fund. Investors should undertake their own due diligence and
carefully evaluate financial products before investing. ADVICE FROM
A SECURITIES PROFESSIONAL IS STRONGLY ADVISED
NDAQG
Nasdaq Media Contact:
Peter Gau
+1 (212) 231-5475 (office)
+1 (646) 633-3246 (mobile)
Peter.Gau@nasdaq.com
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024